Bamforth Mark R 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Oct 27, 2017
Insider Transaction Report
Form 4
Bamforth Mark R
Director
Transactions
- Purchase
Common Stock, $0.001 par value
2017-10-27$4.48/sh+200$895→ 200 total - Purchase
Common Stock, $0.001 par value
2017-10-27$4.49/sh+300$1,347→ 7,293 total - Purchase
Common Stock, $0.001 par value
2017-10-27$4.49/sh+5,340$23,993→ 12,834 total - Purchase
Common Stock, $0.001 par value
2017-10-27$4.51/sh+1,200$5,412→ 50,000 total - Purchase
Common Stock, $0.001 par value
2017-10-27$4.49/sh+4,993$22,399→ 5,193 total - Purchase
Common Stock, $0.001 par value
2017-10-27$4.49/sh+1,800$8,080→ 6,993 total - Purchase
Common Stock, $0.001 par value
2017-10-27$4.49/sh+201$903→ 7,494 total - Purchase
Common Stock, $0.001 par value
2017-10-27$4.51/sh+35,966$162,063→ 48,800 total